{"id":"W4389627613","doi":"10.1080/13696998.2023.2293379","title":"Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom","year":2023,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Cegep de Saint Jerome; Université de Montréal","funders":"Canadian Institutes of Health Research; Sanofi Genzyme; Novartis Pharma; Multiple Sclerosis International Federation; Sanofi; World Health Organization; Bayer HealthCare; Università di Catania; Multiple Sclerosis Society of Canada; Biogen; Celgene; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Atara Biotherapeutics; Eisai; Bristol-Myers Squibb","keywords":"Fingolimod; Medicine; Natalizumab; Relapsing remitting; Multiple sclerosis; Cost effectiveness; Physical therapy; Intensive care medicine; Internal medicine; Immunology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01199246,0.0005729527,0.001743118,0.00106496,0.0001430288,0.001427152,0.0005995636,0.001023713,0.001623987],"category_scores_gemma":[0.04568985,0.0003576638,0.003186515,0.0009608343,0.0006839553,0.0009271734,0.001199808,0.0007595446,0.00008877023],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005141431,"about_ca_system_score_gemma":0.001292996,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01558031,"about_ca_topic_score_gemma":0.01043449,"domain_scores_codex":[0.9740025,0.02230624,0.001342541,0.0007588877,0.001116549,0.0004732622],"domain_scores_gemma":[0.9799395,0.01425482,0.004241428,0.000506419,0.0005863227,0.0004716371],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2480433,0.001266874,0.3026696,0.01417115,0.05881528,0.001586313,0.0009198015,0.1636078,0.002497258,0.007825911,0.003640127,0.1949567],"study_design_scores_gemma":[0.06156974,0.04816604,0.6807891,0.008017807,0.05913271,0.004024116,0.001524243,0.1170294,0.003382505,0.006132458,0.009726184,0.0005057211],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.928534,0.06509984,0.001159703,0.001202879,0.0001306661,0.0002150237,0.001229391,0.00001497442,0.002413625],"genre_scores_gemma":[0.996428,0.002659833,0.0003382374,0.0001366452,0.00001669085,0.00005361859,0.0002776712,0.000002493062,0.0000868775],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01558031,"threshold_uncertainty_score":0.06342298,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1420528960193775,"score_gpt":0.3668817237976787,"score_spread":0.2248288277783012,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}